These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 17221305)
1. Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel. Veltkamp SA; Meerum Terwogt JM; van den Heuvel MM; van Boven HH; Schellens JH; Rodenhuis S Invest New Drugs; 2007 Jun; 25(3):279-81. PubMed ID: 17221305 [No Abstract] [Full Text] [Related]
3. [A Case of Bilateral Pneumothorax after Chemotherapy for Uterine Leiomyosarcoma with Multiple Lung Metastases]. Murakami J; Hori K; Okubo R; Miyagi K; Shiomi M; Uragami K; Nakagawa M; Yoshioka E; Tsuruta T; Tashima R; Ito K Gan To Kagaku Ryoho; 2016 Feb; 43(2):259-61. PubMed ID: 27067695 [TBL] [Abstract][Full Text] [Related]
4. [LEIOMYOSARCOMA ARISING FROM OVARIAN VEIN WITH RIGHT HYDRONEPHROSIS: A CASE REPORT]. Inatsu H; Murata T; Tokunaga M; Nyomura S; Takahashi N; Kondo Y; Tomita K Nihon Hinyokika Gakkai Zasshi; 2015 Jul; 106(3):211-5. PubMed ID: 26419081 [TBL] [Abstract][Full Text] [Related]
5. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. Hensley ML; Maki R; Venkatraman E; Geller G; Lovegren M; Aghajanian C; Sabbatini P; Tong W; Barakat R; Spriggs DR J Clin Oncol; 2002 Jun; 20(12):2824-31. PubMed ID: 12065559 [TBL] [Abstract][Full Text] [Related]
6. Gemcitabine/docetaxel--welcome to a new standard. Fleming G Gynecol Oncol; 2008 Jun; 109(3):313-5. PubMed ID: 18534248 [No Abstract] [Full Text] [Related]
7. Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan. Takano T; Niikura H; Ito K; Nagase S; Utsunomiya H; Otsuki T; Toyoshima M; Tokunaga H; Kaiho-Sakuma M; Shiga N; Nagai T; Tanaka S; Otsuki A; Kurosawa H; Shigeta S; Tsuji K; Yamaguchi T; Yaegashi N Int J Clin Oncol; 2014 Oct; 19(5):897-905. PubMed ID: 24149774 [TBL] [Abstract][Full Text] [Related]
8. Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma. Dunsford ML; Mead GM; Bateman AC; Cook T; Tung K Ann Oncol; 1999 Aug; 10(8):943-7. PubMed ID: 10509156 [TBL] [Abstract][Full Text] [Related]
9. SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancer. Vasey PA; Atkinson R; Osborne R; Parkin D; Symonds R; Paul J; Lewsley L; Coleman R; Reed NS; Kaye S; Rustin GJ Br J Cancer; 2006 Jan; 94(1):62-8. PubMed ID: 16404361 [TBL] [Abstract][Full Text] [Related]
10. Locally advanced leiomyosarcoma of the urinary bladder: near-complete pathologic response to neoadjuvant gemcitabine and docetaxel. Sawhney R; Curry N; Burks T; Chaudhary UB Anticancer Drugs; 2007 Jul; 18(6):745-7. PubMed ID: 17762407 [TBL] [Abstract][Full Text] [Related]
11. Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study. Hensley ML; Miller A; O'Malley DM; Mannel RS; Behbakht K; Bakkum-Gamez JN; Michael H J Clin Oncol; 2015 Apr; 33(10):1180-5. PubMed ID: 25713428 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005). Hensley ML; Wathen JK; Maki RG; Araujo DM; Sutton G; Priebat DA; George S; Soslow RA; Baker LH Cancer; 2013 Apr; 119(8):1555-61. PubMed ID: 23335221 [TBL] [Abstract][Full Text] [Related]
17. Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). Pautier P; Floquet A; Penel N; Piperno-Neumann S; Isambert N; Rey A; Bompas E; Cioffi A; Delcambre C; Cupissol D; Collin F; Blay JY; Jimenez M; Duffaud F Oncologist; 2012; 17(9):1213-20. PubMed ID: 22907974 [TBL] [Abstract][Full Text] [Related]
18. [Two cases of complete response to combination chemotherapy of gemcitabine and docetaxel for recurrent ovarian cancer]. Ito K; Adachi S; Iijima T; Nakatsuji Y; Kimura T; Nobunaga T Gan To Kagaku Ryoho; 2003 Jan; 30(1):141-4. PubMed ID: 12557720 [TBL] [Abstract][Full Text] [Related]
19. [Long-term survival with gemcitabine and docetaxel for renal leiomyosarcoma : a case report]. Nagumo Y; Kimura T; Ichioka D; Uchida M; Oikawa T; Suetomi T; Miyazaki J; Kawai K; Nagata C; Nishiyama H Hinyokika Kiyo; 2013 Aug; 59(8):497-501. PubMed ID: 23995525 [TBL] [Abstract][Full Text] [Related]
20. Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin. Berkenblit A; Tung N; Kim Y; Feyler H; Niloff J; Berghe KV; Cannistra SA Gynecol Oncol; 2003 Jun; 89(3):486-93. PubMed ID: 12798716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]